{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:24:30Z","timestamp":1793751870116,"version":"4.6.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400764"],"award-info":[{"award-number":["82400764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer (PC) is characterized by an exceptionally poor prognosis, primarily attributable to its aggressive metastatic behavior and high recurrence rates. Liver metastasis is the predominant distant metastasis model of PC. Moreover, invasion and metastasis of PC are closely associated with the remodeling or loss of basement membrane (BM). Consequently, identifying pivotal genes involved in PC liver metastasis (PCLM) and BM could pave the way for more effective and precise targeted therapies. This study aims to construct a prognostic model based on PCLM and BM-related genes, while also validating the association between this model and the immune microenvironment of PC, as well as its predictive value for the efficacy of chemotherapy and immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptomic, mutation, and clinical data were retrieved from the TCGA, ICGC, and GEO databases. Core prognostic genes were identified through single-cell (sc) and bulk transcriptomic sequencing data combined with WGCNA analysis. The prognostic model was established using machine learning algorithms and multivariate Cox regression analyses. Specifically, the TCGA-PAAD cohort was utilized as the training set while the PACA-AU cohort served as the validation set. The performance of this model was assessed in both the training and validation sets. Additionally, the associations between the model and tumor mutation burden (TMB) as well as tumor immunity were evaluated using multiple immunity databases. Additionally, the predictive capacity of the model regarding the efficacy of chemotherapy, immunotherapy, and targeted therapy was also assessed. Finally, the expression of COL7A1 was knockdown in cancer-associated fibroblasts (CAFs) in PC to explore its role in PC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>30 PCLM and BM-related prognostic genes were preliminarily identified integrating sc and bulk transcriptomic sequencing data. Through machine learning algorithms and multivariate Cox regression analysis, six signatures, including COL7A1, ITGA6, ITGA7, ITGB5, ITGB7 and NTN4, were subsequently utilized to construct a prognostic model. This model demonstrated superior prognostic performance compared with conventional clinicopathological variables. Immune analysis revealed that the infiltration levels of M0 macrophages and Treg cells were significantly elevated in the high-risk group, whereas the infiltration levels of CD8+T cells and \u03b3\u03b4T cells were significantly reduced. Moreover, the high-risk group exhibited higher TMB and poorer survival outcomes. Additionally, the high-risk group showed a higher TIDE and a lower IPS score, indicating less effective immunotherapy response. Furthermore, the high-risk group displayed significantly higher IC50 values for common PC chemotherapeutics, suggesting reduced chemotherapeutic efficacy. Notably, scRNA-seq analysis indicated that COL7A1, which has not been systematically investigated in PC previously, predominantly expressed in fibroblasts. Specifically, CAFs exhibited significantly higher expression levels of COL7A1 compared to normal pancreatic fibroblasts, and COL7A1 knockdown in CAFs markedly reduced the migratory capacity of PC cells while enhancing their chemosensitivity to gemcitabine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study developed and rigorously validated an innovative prognostic model for PC. This model, incorporating pivotal genes of PCLM and BM, may also serve as potential tool for predicting the tumor immune microenvironment and therapeutic efficacy. Notably, COL7A1, which was demonstrated to be vital in PC metastasis in this study, warrants further investigation in future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1671956","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:47:21Z","timestamp":1761720441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Integration of bulk and single-cell transcriptomic data reveals a novel signature related to liver metastasis and basement membrane in pancreatic cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Dongkai","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00992-4","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0230060","DOI":"10.1371\/journal.pone.0230060","article-title":"The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies","volume":"15","author":"Us\u00f3n","year":"2020","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1002\/mco2.70119","article-title":"Liver metastasis in cancer: molecular mechanisms and management","volume":"6","author":"Xu","year":"2025","journal-title":"MedComm (2020)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923","article-title":"Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02777","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial","volume":"41","author":"Burris","year":"2023","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1038\/s41467-022-32591-8","article-title":"The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma","volume":"13","author":"Renouf","year":"2022","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i20.2137","article-title":"Immune therapies in pancreatic ductal adenocarcinoma: Where are we now","volume":"24","author":"Hilmi","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004911","article-title":"Basement membranes: cell scaffoldings and signaling platforms","volume":"3","author":"Yurchenco","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0584fje","article-title":"Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology","volume":"18","author":"Koshikawa","year":"2004","journal-title":"FASEB J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.8.5023","article-title":"Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype","volume":"176","author":"Hagemann","year":"2006","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4161\/cam.28733","article-title":"Assembly, heterogeneity, and breaching of the basement membranes","volume":"8","author":"Glentis","year":"2014","journal-title":"Cell Adh Migr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.775080","article-title":"Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGF\u03b2 signaling","volume":"292","author":"Lo","year":"2017","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/gs-23-24","article-title":"Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer","volume":"12","author":"Lin","year":"2023","journal-title":"Gland Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7150\/jca.100891","article-title":"Identification of basement membrane-related prognostic model associated with the immune microenvironment and synthetic therapy response in pancreatic cancer: integrated bioinformatics analysis and clinical validation","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112888","article-title":"Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis","volume":"140","author":"Guo","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133507","article-title":"Polarization of cancer-associated macrophages maneuver neoplastic attributes of pancreatic ductal adenocarcinoma","volume":"15","author":"Lin","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197307","article-title":"The immune microenvironment in pancreatic cancer","volume":"21","author":"Huber","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0322","article-title":"T-cell localization, activation, and clonal expansion in human pancreatic ductal adenocarcinoma","volume":"5","author":"Stromnes","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7150\/jca.89665","article-title":"Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma","volume":"15","author":"Zhou","year":"2024","journal-title":"J Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"eabn2265","DOI":"10.1126\/sciadv.abn2265","article-title":"Genomics England Research Consortium; Sherwood DR, Lennon R. A basement membrane discovery pipeline uncovers network complexity, regulators, and human disease associations","volume":"8","author":"Jayadev","year":"2022","journal-title":"Sci Adv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1038\/s41598-020-66986-8","article-title":"ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications","volume":"10","author":"Yi","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1113-y","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132239","article-title":"Discovery of PELATON links to the INHBA gene in the TGF-\u03b2 pathway in colorectal cancer using a combination of bioinformatics and experimental investigations","volume":"270","author":"Abutalebi","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00576","article-title":"Transducin-like enhancer of split-1 inhibits Malignant behaviors in vitro and predicts a better prognosis in pancreatic ductal adenocarcinoma","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14060667","article-title":"Identification and validation of T-cell exhaustion signature for predicting prognosis and immune response in pancreatic cancer by integrated analysis of single-cell and bulk RNA sequencing data","volume":"14","author":"Zhu","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00807-x","article-title":"A novel pancreatic cancer hypoxia status related gene signature for prognosis and therapeutic responses","volume":"66","author":"Ren","year":"2024","journal-title":"Mol Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1364\/OL.523675","article-title":"Foveated pancake lens design for improved optical performance and eye rotation support","volume":"49","author":"Jeong","year":"2024","journal-title":"Opt Lett"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.939542","article-title":"Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma","volume":"13","author":"Tian","year":"2022","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/aging.206043","article-title":"Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis","volume":"16","author":"Ma","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.561254","article-title":"Development and validation of a novel metabolic-related signature predicting overall survival for pancreatic cancer","volume":"12","author":"Huo","year":"2021","journal-title":"Front Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.702102","article-title":"Construction and validation of an immune-based prognostic model for pancreatic adenocarcinoma based on public databases","volume":"12","author":"Mao","year":"2021","journal-title":"Front Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001293","article-title":"Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcinoma: a tumor marker prognostic study","volume":"110","author":"Xu","year":"2024","journal-title":"Int J Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2363043","article-title":"Cuprotosis-related genes: predicting prognosis and immunotherapy sensitivity in pancreatic cancer patients","volume":"2022","author":"Xu","year":"2022","journal-title":"J Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13374-4","article-title":"Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145804","article-title":"Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma","volume":"795","author":"Xu","year":"2021","journal-title":"Gene"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00099-x","article-title":"Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer","volume":"16","author":"Gambelli","year":"2024","journal-title":"EMBO Mol Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jare.2023.03.010","article-title":"Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development","volume":"56","author":"Ying","year":"2024","journal-title":"J Adv Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0879","article-title":"Integrin \u03b27 inhibits colorectal cancer pathogenesis via maintaining antitumor immunity","volume":"9","author":"Zhang","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01433-9","article-title":"Expression of integrin \u03b2-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics","volume":"15","author":"Roy Choudhury","year":"2023","journal-title":"Clin Epigenetics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.gie.2024.02.021","article-title":"Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma (with video)","volume":"100","author":"Kim","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01452-3","article-title":"Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2\/ITGB7\/FAK axis","volume":"39","author":"Sun","year":"2020","journal-title":"Oncogene"},{"key":"B53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-025-03362-2","article-title":"N4-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma","volume":"44","author":"Huang","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1381151","article-title":"ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK\/ERK signaling pathway","volume":"12","author":"Wen","year":"2022","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01484-w","article-title":"Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response","volume":"125","author":"Gwili","year":"2021","journal-title":"Br J Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119785","article-title":"Promoter hypermethylation-induced downregulation of ITGA7 promotes colorectal cancer proliferation and migration by activating the PI3K\/AKT\/NF-\u03baB pathway","volume":"1871","author":"Wang","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102816","article-title":"Netrin family genes as prognostic markers and therapeutic targets for clear cell renal cell carcinoma: netrin-4 acts through the wnt\/\u03b2-catenin signaling pathway","volume":"15","author":"Ke","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.86275","article-title":"EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4\/integrin \u03b21 signalling axis","volume":"20","author":"Huang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1543193","article-title":"COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102701","article-title":"COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage","volume":"15","author":"Koca","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/ol.2023.13663","article-title":"Collagen type VII \u03b11 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer","volume":"25","author":"Ding","year":"2023","journal-title":"Oncol Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59227","article-title":"Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice","volume":"122","author":"Collins","year":"2012","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0489","article-title":"Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model","volume":"15","author":"Liu","year":"2025","journal-title":"Cancer Discov"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101171","article-title":"TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4","volume":"78","author":"He","year":"2025","journal-title":"Drug Resist Updat"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e010029","DOI":"10.1136\/jitc-2024-010029","article-title":"CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment","volume":"13","author":"Xu","year":"2025","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1671956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:47:23Z","timestamp":1761720443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1671956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2025.1671956"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1671956","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1671956"}}